The Hospital Clínic de Barcelona-IDIBAPS has developed a new CAR-T treatment for multiple myeloma, the second most common blood cancer, with encouraging results: “all patients improve, 75% of them maintain the response and not they have disease progression at 12 months, and 60% have complete remission without residual disease “, says Dr. Fernández de Larrea, [...]

20 December 2021